Viraj Chandana Kariyawasam MBBS MRCP FRACP PhD
Viraj Chandana Kariyawasam MBBS MRCP FRACP PhD
Clinical Senior Lecturer, University of Western Sydney
Verified email at - Homepage
Cited by
Cited by
consensus statements on therapeutic drug monitoring of anti‐tumour necrosis factor therapy in inflammatory bowel diseases
N Mitrev, N Vande Casteele, CH Seow, JM Andrews, SJ Connor, ...
Alimentary pharmacology & therapeutics 46 (11-12), 1037-1053, 2017
Smoking prevalence and its influence on disease course and surgery in Crohn's disease and ulcerative colitis
PC Lunney, VC Kariyawasam, RR Wang, KL Middleton, T Huang, ...
Alimentary pharmacology & therapeutics 42 (1), 61-70, 2015
Giant laterally spreading tumors of the duodenum: endoscopic resection outcomes, limitations, and caveats
SB Fanning, MJ Bourke, SJ Williams, A Chung, VC Kariyawasam
Gastrointestinal endoscopy 75 (4), 805-812, 2012
Complete Barrett’s excision by stepwise endoscopic resection in short-segment disease: long term outcomes and predictors of stricture
A Chung, MJ Bourke, LF Hourigan, G Lim, A Moss, SJ Williams, ...
Endoscopy 43 (12), 1025-1032, 2011
Prospective validation study of the International Classification of Functioning, Disability and Health score in Crohn's disease and ulcerative colitis
RWL Leong, T Huang, Y Ko, A Jeon, J Chang, F Kohler, V Kariyawasam
Journal of Crohn's and Colitis 8 (10), 1237-1245, 2014
Inflammatory bowel disease environmental risk factors: a population-based case–control study of Middle Eastern migration to Australia
Y Ko, V Kariyawasam, M Karnib, R Butcher, D Samuel, A Alrubaie, ...
Clinical Gastroenterology and Hepatology 13 (8), 1453-1463. e1, 2015
Circumferential location predicts the risk of high-grade dysplasia and early adenocarcinoma in short-segment Barrett's esophagus
VC Kariyawasam, MJ Bourke, LF Hourigan, G Lim, A Moss, SJ Williams, ...
Gastrointestinal endoscopy 75 (5), 938-944, 2012
Early use of thiopurines or methotrexate reduces major abdominal and perianal surgery in Crohn's disease
VC Kariyawasam, CP Selinger, PH Katelaris, DB Jones, C McDonald, ...
Inflammatory bowel diseases 20 (8), 1382-1390, 2014
acute severe ulcerative colitis–evidence‐based consensus statements
JH Chen, JM Andrews, V Kariyawasam, N Moran, P Gounder, G Collins, ...
Alimentary pharmacology & therapeutics 44 (2), 127-144, 2016
Prevalence and Risk Factors for Functional Vitamin B12 Deficiency in Patients with Crohn's Disease
MG Ward, VC Kariyawasam, SB Mogan, KV Patel, M Pantelidou, ...
Inflammatory bowel diseases 21 (12), 2839-2847, 2015
Major abdominal and perianal surgery in Crohn’s disease: long-term follow-up of Australian patients with Crohn’s disease
JWT Toh, N Wang, CJ Young, MJFX Rickard, A Keshava, P Stewart, ...
Diseases of the Colon & Rectum 61 (1), 67-76, 2018
Thioguanine in inflammatory bowel disease: Long-term efficacy and safety
MG Ward, KV Patel, VC Kariyawasam, R Goel, B Warner, TR Elliott, ...
United European gastroenterology journal 5 (4), 563-570, 2017
Thiopurines dosed to a therapeutic 6-thioguanine level in combination with adalimumab are more effective than subtherapeutic thiopurine-based combination therapy or adalimumab …
VC Kariyawasam, MG Ward, PA Blaker, KV Patel, R Goel, JD Sanderson, ...
Inflammatory bowel diseases 23 (9), 1555-1565, 2017
Medication non-adherence in inflammatory bowel diseases is associated with disability
J Perry, A Chen, V Kariyawasam, G Collins, C Choong, WL Teh, N Mitrev, ...
Intestinal research 16 (4), 571, 2018
IBD Sydney Organisation and the Australian Inflammatory Bowel Diseases Consensus Working Group. Review article: acute severe ulcerative colitis–evidence-based consensus statements
JH Chen, JM Andrews, V Kariyawasam, N Moran, P Gounder, G Collins, ...
Aliment Pharmacol Ther 44 (2), 127-44, 2016
Australian tertiary care outcomes of entecavir monotherapy in treatment naive patients with chronic hepatitis B
F Fahrtash-Bahin, VC Kariyawasam, T Gray, K Byth, J George, ...
World Journal of Gastroenterology: WJG 19 (5), 721, 2013
Clinical utility of measuring adalimumab trough levels and antibodies to adalimumab in patients with inflammatory bowel diseases
M Ward, V Kariyawasam, S Mogan, P Blaker, K Patel, M Pantelidou, ...
Journal of Gastroenterology and Hepatology 28, 100-101, 2013
Epidemiology and outcomes of primary sclerosing cholangitis with and without inflammatory bowel disease in an Australian cohort
K Liu, R Wang, V Kariyawasam, M Wells, SI Strasser, G McCaughan, ...
Liver International 37 (3), 442-448, 2017
343 azathioprine decreases the risk of adalimumab primary non-response and secondary loss of response but only if adequately dosed
VC Kariyawasam, MG Ward, PA Blaker, SH Anderson, JD Sanderson, ...
Gastroenterology 146 (5), S-79, 2014
Intestinal mucosal leakage is detected using in vivo confocal endomicroscopy in macroscopically-normal Crohn's disease and ulcerative colitis
RW Leong, B Wong, J Chen, E Chung, J Mill, VC Kariyawasam, ...
Journal of Gastroenterology and Hepatology (Australia) 27 (S4), 109-110, 2012
The system can't perform the operation now. Try again later.
Articles 1–20